The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia.
OBJECTIVE
To determine the effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia, in whom a single dose of intravesical capsaicin (1-2 mmol/L) increases the bladder capacity for 3-6 months.


METHODS
Thirteen patients with detrusor hyper-reflexia underwent cystometry and had flexible cystoscopic biopsies taken before and 6 weeks after receiving instillations of intravesical capsaicin (1 mmol/L). Similar biopsies were also obtained from a control group of 12 neurologically normal patients with microscopic haematuria and normal bladders. Frozen sections were stained using antibodies to S100 and PGP 9.5. Using computerized analysis, the mean nerve density scores were expressed as nerves/mm2 for S100-positive structures and 'red%' and 'red in frame' for PGP 9.5.


RESULTS
The mean (SEM) functional bladder capacity increased from 193.2 (28.17) mL before to 396.3 (41.96) mL at 6 weeks after treatment with capsaicin, in nine of the 13 patients. The mean nerve density of S100-positive structures in the control group was 83 (3.18) nerves/mm2. In hyper-reflexic patients who responded to capsaicin by improved bladder capacity, the mean nerve density of S100-positive structures was reduced from 100 (12.2) before to 66 (9.4) nerves/mm2 6 weeks after treatment. In those who did not respond to capsaicin there was no significant difference in these scores. Similarly the 'red%' and 'red in frame' reduced from 3.41 (1.06) to 1.15 (0.32) and 824.7 (246.3) to 297.9 (83.5) units, respectively, before and 6 weeks after capsaicin treatment. The difference in those not responding was not significant.


CONCLUSIONS
Intravesical capsaicin causes a reduction in suburothelial nerve densities in the bladder of patients with detrusor hyper-reflexia. This may explain its prolonged beneficial effect in these patients.
Dasgupta
P
P
Departments of Uro-Neurology and Neuropathology, Institute of Neurology, Queen Square, London, UK.
Chandiramani
V A
VA
Beckett
A
A
Scaravilli
F
F
Fowler
C J
CJ
D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D000943:Antigens, Differentiation / Q000378:metabolism; D002211:Capsaicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D012021:Reflex, Abnormal; D009418:S100 Proteins / Q000378:metabolism; D043222:Ubiquitin Thiolesterase; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D019459:Urothelium / Q000294:innervation*
D000943:Antigens, Differentiation; D009418:S100 Proteins; D043222:Ubiquitin Thiolesterase; D002211:Capsaicin